Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients.
about
A phase I/II study of rituximab and etanercept in patients with chronic lymphocytic leukemia and small lymphocytic lymphomaRituximab: clinical development and future directions.Antibody therapy for chronic lymphocytic leukemia.Critical appraisal of the role of rituximab in the treatment of patients with previously untreated or treated chronic lymphocytic leukemia (CLL).Antibody-based therapy of leukaemia.Investigational immunotherapeutics for B-cell malignancies.Treatment of relapsed or refractory chronic lymphocytic leukemia.Rituximab: current status as therapy for malignant and benign hematologic disorders.Rituximab for the treatment of patients with chronic lymphocytic leukemia
P2860
Q33905245-37DA8814-C271-4A2D-B24B-C417AAF35588Q34482081-D3F0DBCC-63A8-4226-8274-35CA3EB85370Q34589909-E63F3AEB-1BE9-4723-B1EC-043BA270A487Q35683808-79093734-4CC1-4346-9D68-B6FFA6ED82BBQ37605247-C052371F-8FDF-4396-91C5-7CFF89C91418Q37667386-BAC94BB1-5C4E-4134-B6BE-769AE9B324A6Q37964916-5C8923B5-07D8-4A85-9830-CEA02EEC319BQ37984551-46ABD41C-93E1-41AC-8D30-8201D97F2BBDQ41241909-BA024619-E8A4-42F2-960A-3D7061DCD4D7
P2860
Rituximab anti-CD20 monoclonal antibody induces marked but transient reductions of peripheral blood lymphocytes in chronic lymphocytic leukaemia patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Rituximab anti-CD20 monoclonal ...... ymphocytic leukaemia patients.
@en
type
label
Rituximab anti-CD20 monoclonal ...... ymphocytic leukaemia patients.
@en
prefLabel
Rituximab anti-CD20 monoclonal ...... ymphocytic leukaemia patients.
@en
P2093
P356
P1433
P1476
Rituximab anti-CD20 monoclonal ...... ymphocytic leukaemia patients.
@en
P2093
P2888
P304
P356
10.1007/BF02780529
P577
2000-08-01T00:00:00Z
P6179
1018325767